Ovid Therapeutics
OVID
#9137
Rank
ยฃ86.27 M
Marketcap
ยฃ1.21
Share price
3.18%
Change (1 day)
35.81%
Change (1 year)

Revenue for Ovid Therapeutics (OVID)

Revenue in 2025 (TTM): ยฃ4.85 Million

According to Ovid Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ4.97 Million. In 2024 the company made a revenue of ยฃ0.45 Million an increase over the revenue in the year 2023 that were of ยฃ0.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ovid Therapeutics from 2016 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ4.85 M977.18%
2024 ยฃ0.45 M46.75%
2023 ยฃ0.3 M-75.26%
2022 ยฃ1.24 M-99.2%
2021 ยฃ0.15 B1567.76%
2020 ยฃ9.25 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA